Hi Supertramp, Yes that is helpful discussion. Did the Vitrocard...

Hi Supertramp,
Yes that is helpful discussion. Did the Vitrocard data line not include a placebo then? If not, and the current trial does, then that is a good outcome. I imagine the lines (June,Aug,Oct&Nov) all represent a group who's trial began on that month. They all had a negative alteration at 8 weeks, and I wonder why, and if this is placebo group caused or something else. Also am I right that the Mag 1 were the easier group that the Mag 2.? If that is the case, and there was no placebo in the vitrocard trial, then the result is outstanding at week 8, and even at the completion is still quite good. But that won't be known till the trial us unmasked.
Would the results be unmasked to management as they are completed or must the whole of the trial be completed before it can be looked at? I expect the latter. Anyway on the surface it does seem the product is still as good as we believed a long time ago. Share price has dived more than one would think is reasonable and I can't see any result justification as to why. Maybe its a time to buy, but i'm in that group damaged by the slaughter, and stuck my hand in again at 5.5 .
Cheers.